{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:33:26Z","timestamp":1744173206160,"version":"3.40.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1007\/s11908-002-0004-4","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T03:02:33Z","timestamp":1180062153000},"page":"377-386","source":"Crossref","is-referenced-by-count":22,"title":["Pathogenesis, therapy, and prevention of meningococcal sepsis"],"prefix":"10.1007","volume":"4","author":[{"given":"David S.","family":"Stephens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanta M.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"4_CR1","first-page":"20.1","volume-title":"Infectious Diseases","author":"N Rosenstein","year":"1999","unstructured":"Rosenstein N, Pinner RW, Stephens DS: Epidemic meningitis.In Infectious Diseases. Edited by Armstrong D, Cohen J. London: Mosby; 1999:20.1\u201320.4."},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jama.273.5.383","volume":"273","author":"LA Jackson","year":"1995","unstructured":"Jackson LA, Schuchat A, Reeves MW, Wenger JD: Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA 1995, 273:383\u2013389.","journal-title":"JAMA"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2958.1994.tb00285.x","volume":"11","author":"M Achtman","year":"1994","unstructured":"Achtman M: Clonal spread of serogroup A meningococci: a paradigm for the analysis of microevolution in bacteria. Mol Microbiol 1994, 11:15\u201322.","journal-title":"Mol Microbiol"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1073\/pnas.83.13.4927","volume":"83","author":"DA Caugant","year":"1986","unstructured":"Caugant DA, Froholm LO, Bovre K, et al.: Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci U S A 1986, 83:4927\u20134931.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/S0140-6736(00)03502-9","volume":"356","author":"MK Taha","year":"2000","unstructured":"Taha MK, Achtman M, Alonso JM, et al.: Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000, 356:2159.","journal-title":"Lancet"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1001\/jama.276.23.1866","volume":"276","author":"Centers for Diseases Control and Prevention","year":"1996","unstructured":"Centers for Diseases Control and Prevention: Serogroup Y meningococcal disease\u2014Illinois, Connecticut and selected areas, United States, 1989\u20131996. JAMA 1996, 276:1866\u20131867.","journal-title":"JAMA"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-123-12-199512150-00007","volume":"123","author":"DS Stephens","year":"1995","unstructured":"Stephens DS, Hajjeh RA, Baughman WS, et al.: Sporadic meningococcal disease in adults: results of a 5-year populationbased study. Ann Intern Med 1995, 123:937\u2013940.","journal-title":"Ann Intern Med"},{"key":"4_CR8","first-page":"2228","volume-title":"Principles and Practiceof Infectious Diseases","author":"MA Apicella","year":"2000","unstructured":"Apicella MA: Neisseria meningitidis. In Principles and Practiceof Infectious Diseases. Edited by MandellGL, DouglasRGJr, Bennett JE. New York: Churchill Livingstone; 2000:2228\u20132241."},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1084\/jem.161.6.1539","volume":"161","author":"DS Stephens","year":"1985","unstructured":"Stephens DS, Whitney AM, Rothbard J, Schoolnik GK: Pili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal pili. J Exp Med 1985, 161:1539\u20131553.","journal-title":"J Exp Med"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"21777","DOI":"10.1074\/jbc.273.34.21777","volume":"273","author":"H Kallstrom","year":"1998","unstructured":"Kallstrom H, Islam MS, Berggren PO, Jonsson AB: Cell signaling by the type IV pili of pathogenic Neisseria. J Biol Chem 1998, 273:21777\u201321782.","journal-title":"J Biol Chem"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/373357a0","volume":"373","author":"T Rudel","year":"1995","unstructured":"Rudel T, Scheurerpflug I, Meyer TF: Neisseria PilC protein identified as type-4 pilus tip-located adhesin. Nature 1995, 373:357\u2013359.","journal-title":"Nature"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/10408419891294216","volume":"24","author":"CM Kahler","year":"1998","unstructured":"Kahler CM, Stephens DS: Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit Rev Microbiol 1998, 24:281\u2013334. Review of meningococcal endotoxin.","journal-title":"Crit Rev Microbiol"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0882-4010(92)90022-G","volume":"13","author":"DM Jones","year":"1992","unstructured":"Jones DM, Borrow R, Fox AJ, et al.: The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb Pathog 1992, 13:219\u2013224.","journal-title":"Microb Pathog"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1084\/jem.168.1.107","volume":"168","author":"RE Mandrell","year":"1988","unstructured":"Mandrell RE, Griffiss JM, Macher BA: Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. J Exp Med 1988, 168:107\u2013126.","journal-title":"J Exp Med"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1073\/pnas.94.1.271","volume":"94","author":"JS Swartley","year":"1997","unstructured":"Swartley JS, Marfin AA, Edupuganti S, et al.: Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A 1997, 94:271\u2013276.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/JB.180.6.1533-1539.1998","volume":"180","author":"JS Swartley","year":"1998","unstructured":"Swartley JS, Liu LJ, Miller YK, et al.: Characterization of the gene cassette required for biosynthesis of the (_166)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis. J Bacteriol 1998, 180:1533\u20131539.","journal-title":"J Bacteriol"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/j.1365-2958.1996.tb02641.x","volume":"20","author":"S Hammerschmidt","year":"1996","unstructured":"Hammerschmidt S, Muller A, Sillmann H, et al.: Capsule phase variation in Neisseria meningitidis serogroup B by slippedstrand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol 1996, 20:1211\u20131220.","journal-title":"Mol Microbiol"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/j.1460-2075.1996.tb00347.x","volume":"15","author":"S Hammerschmidt","year":"1996","unstructured":"Hammerschmidt S, Hilse R, van Putten JP, et al.: Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J 1996, 15:192\u2013198.","journal-title":"EMBO J"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1128\/IAI.66.12.5939-5947.1998","volume":"66","author":"CM Kahler","year":"1998","unstructured":"Kahler CM, Martin LE, Shih GC, et al.: The (268)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect Immun 1998, 66:5939\u20135947.","journal-title":"Infect Immun"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/infdis\/167.2.475","volume":"167","author":"DS Stephens","year":"1993","unstructured":"Stephens DS, Spellman PA, Swartley JS: Effect of the (268)-linked polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal cells. J Infect Dis 1993, 167:475\u2013479.","journal-title":"J Infect Dis"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/IAI.67.5.2552-2560.1999","volume":"67","author":"AK Lehmann","year":"1999","unstructured":"Lehmann AK, Halstensen A, Aaberge IS, et al.: Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect Immun 1999, 67:2552\u20132560.","journal-title":"Infect Immun"},{"key":"4_CR22","first-page":"377","volume-title":"BacterialOuter Membranes As Model Systems","author":"MS Blake","year":"1987","unstructured":"Blake MS, Gotschlich EC: Functional and immunologic propertiesof pathogenic Neisseria surface proteins. In BacterialOuter Membranes As Model Systems. Edited by InouyeM. New York: John Wiley & Sons; 1987:377\u2013400."},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/emboj\/18.2.339","volume":"18","author":"A Muller","year":"1999","unstructured":"Muller A, Gunther D, Dux F, et al.: Neisserial porin (PorB) causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine proteases. EMBO J 1999, 18:339\u2013352.","journal-title":"EMBO J"},{"key":"4_CR24","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1128\/IAI.67.5.2406-2413.1999","volume":"67","author":"JP Derrick","year":"1999","unstructured":"Derrick JP, Urwin R, Suker J, et al.: Structural and evolutionary inference from molecular variation in Neisseria porins. Infect Immun 1999, 67:2406\u20132413.","journal-title":"Infect Immun"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1046\/j.1365-2958.1996.01548.x","volume":"22","author":"M Virji","year":"1996","unstructured":"Virji M, Watt SM, Barker S, et al.: The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol Microbiol 1996, 22:929\u2013939.","journal-title":"Mol Microbiol"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1046\/j.1365-2958.1998.00763.x","volume":"27","author":"FP de Vries","year":"1998","unstructured":"de VriesFP, Cole R, Dankert J, et al.: Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors. Mol Microbiol 1998, 27:1203\u20131212.","journal-title":"Mol Microbiol"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1046\/j.1365-2958.1999.01411.x","volume":"32","author":"AB Schryvers","year":"1999","unstructured":"Schryvers AB, Stojiljkovic I: Iron acquisition systems in the pathogenic Neisseria. Mol Microbiol 1999, 32:1117\u20131123. Review of an important virulence mechanism.","journal-title":"Mol Microbiol"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1084\/jem.138.5.1156","volume":"138","author":"IW Devoe","year":"1973","unstructured":"Devoe IW, Gilchrist JE: Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J Exp Med 1973, 138:1156\u20131167.","journal-title":"J Exp Med"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","volume":"95","author":"MC Maiden","year":"1998","unstructured":"Maiden MC, Bygraves JA, Feil E, et al.: Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998, 95:3140\u20133145.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1086\/514123","volume":"176","author":"NJ Raymond","year":"1997","unstructured":"Raymond NJ, Reeves M, Ajello G, et al.: Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. J Infect Dis 1997, 176:1277\u20131284.","journal-title":"J Infect Dis"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/515622","volume":"178","author":"GR Jones","year":"1998","unstructured":"Jones GR, Christodoulides M, Brooks JL, et al.: Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonization. J Infect Dis 1998, 178:451\u2013459.","journal-title":"J Infect Dis"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0140-6736(98)00279-7","volume":"353","author":"DS Stephens","year":"1999","unstructured":"Stephens DS: Uncloaking the meningococcus: dynamics of carriage and disease. Lancet 1999, 353:941\u2013942.","journal-title":"Lancet"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1128\/JCM.40.3.1083-1084.2002","volume":"40","author":"MK Taha","year":"2002","unstructured":"Taha MK, Parent Du Chatelet I, Schlumberger M, et al.: Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 2002, 40:1083\u20131084.","journal-title":"J Clin Microbiol"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/infdis\/123.1.67","volume":"123","author":"S Greenfield","year":"1971","unstructured":"Greenfield S, Sheehe PR, Feldman HA: Meningococcal carriage in a population of \"normal\" families. J Infect Dis 1971, 123:67\u201373.","journal-title":"J Infect Dis"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0950268800059367","volume":"104","author":"CC Blackwell","year":"1990","unstructured":"Blackwell CC, Weir DM, James VS, et al.: Secretor status, smoking and carriage of Neisseria meningitidis. Epidemiol Infect 1990, 104:203\u2013209.","journal-title":"Epidemiol Infect"},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/137.2.112","volume":"137","author":"R Gold","year":"1978","unstructured":"Gold R, Goldschneider I, Lepow ML, et al.: Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 1978, 137:112\u2013121.","journal-title":"J Infect Dis"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(84)91830-0","volume":"1","author":"BM Greenwood","year":"1984","unstructured":"Greenwood BM, Blakebrough IS, Bradley AK, et al.: Meningococcal disease and season in sub-Saharan Africa. Lancet 1984, 1:1339\u20131342.","journal-title":"Lancet"},{"key":"4_CR38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2105\/AJPH.89.5.712","volume":"89","author":"HR Yusuf","year":"1999","unstructured":"Yusuf HR, Rochat RW, Baughman WS, et al.: Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989\u20131996. Am J Public Health 1999, 89:712\u2013717.","journal-title":"Am J Public Health"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/jama.264.10.1271","volume":"264","author":"PS Moore","year":"1990","unstructured":"Moore PS, Hierholzer J, DeWitt W, et al.: Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA 1990, 264:1271\u20131275.","journal-title":"JAMA"},{"key":"4_CR40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/infdis\/148.3.369","volume":"148","author":"DS Stephens","year":"1983","unstructured":"Stephens DS, Hoffman LH, McGee ZA: Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: attachment and entry into columnar epithelial cells. J Infect Dis 1983, 148:369\u2013376.","journal-title":"J Infect Dis"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/clinids\/13.1.22","volume":"13","author":"DS Stephens","year":"1991","unstructured":"Stephens DS, Farley MM: Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. Rev Infect Dis 1991, 13:22\u201333.","journal-title":"Rev Infect Dis"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","volume":"129","author":"I Goldschneider","year":"1969","unstructured":"Goldschneider I, Gotschlich EC, Artenstein MS: Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969, 129:1307\u20131326.","journal-title":"J Exp Med"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJM198304213081601","volume":"308","author":"RTD Ellison","year":"1983","unstructured":"Ellison RTD, Kohler PF, Curd JG, et al.: Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med 1983, 308:913\u2013916.","journal-title":"N Engl J Med"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF02918259","volume":"12","author":"J Figueroa","year":"1993","unstructured":"Figueroa J, Andreoni J, Densen P: Complement deficiency states and meningococcal disease. Immunol Res 1993, 12:295\u2013311.","journal-title":"Immunol Res"},{"key":"4_CR45","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.4049\/jimmunol.114.6.1779","volume":"114","author":"JM Griffiss","year":"1975","unstructured":"Griffiss JM: Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera. J Immunol 1975, 114:1779\u20131784.","journal-title":"J Immunol"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/infdis\/170.2.449","volume":"170","author":"M Schlesinger","year":"1994","unstructured":"Schlesinger M, Greenberg R, Levy J, et al.: Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency. J Infect Dis 1994, 170:449\u2013453.","journal-title":"J Infect Dis"},{"key":"4_CR47","first-page":"219","volume-title":"BacterialEndotoxins: Lipopolysaccharides from Genes to Therapy","author":"P Brandtzaeg","year":"1995","unstructured":"Brandtzaeg P, Ovstebo R, Kierulf P: Bacteremia and compartmentalizationof LPS in meningococcal disease. In BacterialEndotoxins: Lipopolysaccharides from Genes to Therapy. Edited byLevin J, Alving CR, Munford RS, Redl H. New York: Wiley-Liss; 1995:219\u2013233."},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1074\/jbc.274.16.10689","volume":"274","author":"JC Chow","year":"1999","unstructured":"Chow JC, Young DW, Golenbock DT, et al.: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999, 274:10689\u201310692.","journal-title":"J Biol Chem"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"12156","DOI":"10.1073\/pnas.211445098","volume":"98","author":"A Visintin","year":"2001","unstructured":"Visintin A, Mazzoni A, Spitzer JA, Segal DM: Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci U S A 2001, 98:12156\u201312161.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"12654","DOI":"10.1073\/pnas.231471798","volume":"98","author":"T Horng","year":"2001","unstructured":"Horng T, Medzhitov R: Drosophila MyD88 is an adapter in the Toll signaling pathway. Proc Natl Acad Sci U S A 2001, 98:12654\u201312658.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJM200108093450603","volume":"345","author":"SN Faust","year":"2001","unstructured":"Faust SN, Levin M, Harrison SB, et al.: Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001, 345:408\u2013416. Review of protein C activation in meningococcemia.","journal-title":"N Engl J Med"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0140-6736(98)09376-3","volume":"354","author":"RGJ Westendorp","year":"1999","unstructured":"Westendorp RGJ, Hottenga J-J, Slagboom PE: Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 1999, 354:561\u2013563.","journal-title":"Lancet"},{"key":"4_CR53","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/infdis\/170.4.848","volume":"170","author":"RG Bredius","year":"1994","unstructured":"Bredius RG, Derkx BH, Fijen CA, et al.: Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994, 170:848\u2013853.","journal-title":"J Infect Dis"},{"key":"4_CR54","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/174.4.878","volume":"174","author":"S Nadel","year":"1996","unstructured":"Nadel S, Newport MJ, Booy R, Levin M: Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996, 174:878\u2013880.","journal-title":"J Infect Dis"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1086\/322798","volume":"184","author":"RC Read","year":"2001","unstructured":"Read RC, Pullin J, Gregory S, et al.: A functional polymorphism of Toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 2001, 184:640\u2013642.","journal-title":"J Infect Dis"},{"key":"4_CR56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.1947.02880230023006","volume":"134","author":"WR Hill","year":"1947","unstructured":"Hill WR, Kinney TD: The cutaneous lesions in acute meningococcemia. JAMA 1947, 134:513\u2013518.","journal-title":"JAMA"},{"key":"4_CR57","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/clinids\/24.Supplement_1.S98","volume":"24","author":"BA Oppenheim","year":"1997","unstructured":"Oppenheim BA: Antibiotic resistance in Neisseria meningitidis. Clin Infect Dis 1997, 24(Suppl):S98-S101.","journal-title":"Clin Infect Dis"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1086\/315158","volume":"180","author":"NE Rosenstein","year":"1999","unstructured":"Rosenstein NE, Perkins BA, Popovic T, et al., and the ActiveSurveillance Team: The changing epidemiology of meningococcal disease in the United States: active surveillance 1992\u20131996. J Infect Dis 1999, 180:1894\u20131901.","journal-title":"J Infect Dis"},{"key":"4_CR59","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/CMR.13.1.144-166.2000","volume":"13","author":"M Van Deuren","year":"2000","unstructured":"Van DeurenM, Brandtzaeg P, van der MeerJW: Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000, 13:144\u2013166.","journal-title":"Clin Microbiol Rev"},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, Vincent J-L, Laterre P-F, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699\u2013709.","journal-title":"N Engl J Med"},{"key":"4_CR61","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1182\/blood.V96.12.3719","volume":"96","author":"B White","year":"2000","unstructured":"White B, Livingstone W, Murphy C, et al.: An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 2000, 96:3719\u20133724.","journal-title":"Blood"},{"key":"4_CR62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jlb.64.1.14","volume":"64","author":"P Elsbach","year":"1998","unstructured":"Elsbach P: The bactericidal\/permeability-increasing protein (BPI) in antibacterial host defense. J Leukocyte Biol 1998, 64:14\u201318.","journal-title":"J Leukocyte Biol"},{"key":"4_CR63","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/brain\/124.9.1734","volume":"124","author":"SL Leib","year":"2001","unstructured":"Leib SL, Clements JM, Luindberg RL, et al.: Inhibition of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 2001, 124:1734\u20131742.","journal-title":"Brain"},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(97)03227-3","volume":"350","author":"JB Robbins","year":"1997","unstructured":"Robbins JB, Towne DW, Gotschlich EC, Schneerson R: \"Love\u2019s labours lost\": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa. Lancet 1997, 350:880\u2013882.","journal-title":"Lancet"},{"key":"4_CR65","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/infdis\/171.3.632","volume":"171","author":"PA Twumasi Jr","year":"1995","unstructured":"Twumasi PA Jr, Kumah S, Leach A, et al.: A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis 1995, 171:632\u2013638.","journal-title":"J Infect Dis"},{"key":"4_CR66","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0264-410X(97)00030-3","volume":"15","author":"SR Andersen","year":"1997","unstructured":"Andersen SR, Bjune G, Hoiby EA, et al.: Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response. Vaccine 1997, 15:1225\u20131234.","journal-title":"Vaccine"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-002-0004-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-002-0004-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-002-0004-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-002-0004-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:36:45Z","timestamp":1744166205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-002-0004-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s11908-002-0004-4","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"type":"print","value":"1523-3847"},{"type":"electronic","value":"1534-3146"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}